Mark Pruzanski
Direttore/Membro del Consiglio presso EQUILLIUM, INC.
Patrimonio netto: 35 699 $ in data 31/05/2024
Profilo
Mark E.
Pruzanski is the founder of Kirax Corp.
(founded in 2005), Intercept Pharmaceuticals, Inc. (founded in 2002), and Apple Tree Venture Management Llc (founded in 1999).
Dr. Pruzanski's current job(s) include Chairman & Chief Executive Officer at Versanis Bio, Inc. (since 2022), Director at Biotechnology Innovation Organization, Director at Foundation for the Defense of Democracies, Director at eGenesis, Inc., Independent Director at Equillium, Inc. (since 2018), and Director at Intercept Pharma Europe Ltd.Dr. Pruzanski's former job(s) include Chief Executive Officer at MedicinePlanet, Inc., President & Chief Executive Officer at gIcare Pharma, Inc., Director at Evelo Biosciences, Inc., and Entrepreneur-in-Residence at Oak Investment Partners.
Dr. Pruzanski's education history includes an undergraduate degree from McGill University, a doctorate degree from McMaster University, a graduate degree from Paul H.
Nitze School of Advanced International Studies (IT), and a graduate degree from Johns Hopkins University School of Advanced International.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
EQUILLIUM, INC.
0.07% | 22/05/2024 | 23 799 ( 0.07% ) | 35 699 $ | 31/05/2024 |
Posizioni attive di Mark Pruzanski
| Società | Posizione | Inizio |
|---|---|---|
| EQUILLIUM, INC. | Direttore/Membro del Consiglio | 01/09/2018 |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Amministratore Delegato | 01/04/2022 |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK. | Direttore/Membro del Consiglio | 19/08/2015 |
| Foundation for the Defense of Democracies | Direttore/Membro del Consiglio | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direttore/Membro del Consiglio | - |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Mark Pruzanski
| Società | Posizione | Fine |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Fondatore | 08/11/2023 |
| EVELO BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/01/2017 |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Fondatore | 01/07/2002 |
| ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Mark Pruzanski
| McMaster University | Doctorate Degree |
| McGill University | Undergraduate Degree |
| Paul H. Nitze School of Advanced International Studies (IT) | Graduate Degree |
| Johns Hopkins University School of Advanced International | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| EQUILLIUM, INC. | Health Technology |
| Aziende private | 10 |
|---|---|
| MedicinePlanet, Inc. | |
gIcare Pharma, Inc.
 gIcare Pharma, Inc. Pharmaceuticals: MajorHealth Technology gIcare Pharma, Inc. develops gastrointestinal drugs. It develops orally-administered drug GIC-1001 which provides colonic analgesia. The company was founded by Patrick Colin and Maxime Ranger in 2011 and is headquartered in Montreal, Canada. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
| Foundation for the Defense of Democracies | |
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Finance |
Oak Investment Partners
 Oak Investment Partners Investment ManagersFinance Oak Investment Partners (Oak Investment Partners) is a venture capital firm founded in 1978 by Ed F Glassmeyer and Stewart H Greenfield. The firm is headquartered in Wilton, Connecticut. | Finance |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Health Technology |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK. | Commercial Services |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Health Technology |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Mark Pruzanski
